{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:16Z","timestamp":1786985776195,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST110-2320-B-110-006"],"award-info":[{"award-number":["MOST110-2320-B-110-006"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cbi.2022.109978","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T03:03:35Z","timestamp":1652238215000},"page":"109978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells"],"prefix":"10.1016","volume":"361","author":[{"given":"Jing-Ting","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.109978_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2022.109978_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2022.109978_bib3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/febs.13190","article-title":"BH3-only proteins: a 20-year stock-take","volume":"282","author":"Doerflinger","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2022.109978_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10495-008-0300-z","article-title":"Bcl2 family proteins in carcinogenesis and the treatment of cancer","volume":"14","author":"Frenzel","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2022.109978_bib5","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Yip","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2022.109978_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2018.11.004","article-title":"BH3-mimetic drugs: blazing the trail for new cancer medicines","volume":"34","author":"Merino","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cbi.2022.109978_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.118987","article-title":"It's time to die: BH3 mimetics in solid tumors","volume":"1868","author":"Kehr","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.cbi.2022.109978_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41419-021-03500-6","article-title":"The application of BH3 mimetics in myeloid leukemias","volume":"12","author":"Parry","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.109978_bib9","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2022.109978_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.seminhematol.2014.05.008","article-title":"Targeting BCL2 for the treatment of lymphoid malignancies","volume":"51","author":"Anderson","year":"2014","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cbi.2022.109978_bib11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tips.2020.09.004","article-title":"BH3 mimetics in AML therapy: death and beyond?","volume":"41","author":"Cerella","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2022.109978_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100672","article-title":"Targeting MCL-1 in hematologic malignancies: rationale and progress","volume":"44","author":"Wei","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.cbi.2022.109978_bib13","first-page":"751","article-title":"Clinically relevant interactions of anti-apoptotic Bcl-2 protein inhibitors with ABC transporters","volume":"72","author":"Ruzickova","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.cbi.2022.109978_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nchembio.1246","article-title":"Structure-guided design of a selective BCL-XL inhibitor","volume":"9","author":"Lessene","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cbi.2022.109978_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.561","article-title":"Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)","volume":"6","author":"Leverson","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.109978_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","article-title":"Targeting MCL-1 in cancer: current status and perspectives","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2022.109978_bib17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/cells9051287","article-title":"Inhibition of anti-apoptotic bcl-2 proteins in preclinical and clinical studies: current overview in cancer","volume":"9","author":"D'Aguanno","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2022.109978_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10495-013-0910-y","article-title":"The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA","volume":"19","author":"Soderquist","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2022.109978_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","article-title":"Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance","volume":"11","author":"Kapoor","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.109978_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/carcin\/bgr297","article-title":"Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment","volume":"33","author":"McHale","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2022.109978_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00204-016-1753-4","article-title":"Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells","volume":"91","author":"Chen","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2022.109978_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2018.09.008","article-title":"The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells","volume":"358","author":"Chen","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2022.109978_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10565-019-09495-3","article-title":"Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS\/p38 MAPK\/AMPK\/TET2\/FOXP3 axis","volume":"36","author":"Chiou","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.cbi.2022.109978_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114544","article-title":"Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells","volume":"188","author":"Chiou","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2022.109978_bib25","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.2020006785","article-title":"BCL2 and MCL1 inhibitors for hematologic malignancies","volume":"138","author":"Roberts","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2022.109978_bib26","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3390\/cancers13133175","article-title":"Transcript-level dysregulation of BCL2 family genes in acute myeloblastic leukemia","volume":"13","author":"Handschuh","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2022.109978_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2022.109978_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijbiomac.2021.07.133","article-title":"Carboxyl group-modified \u03b1-lactalbumin induces TNF-\u03b1-mediated apoptosis in leukemia and breast cancer cells through the NOX4\/p38 MAPK\/PP2A axis","volume":"187","author":"Chiou","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cbi.2022.109978_bib29","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1002\/jcp.30407","article-title":"NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells","volume":"236","author":"Chiou","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2022.109978_bib30","doi-asserted-by":"crossref","first-page":"26495","DOI":"10.1074\/jbc.M112.376319","article-title":"Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin","volume":"287","author":"Grande","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2022.109978_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jop.12787","article-title":"Role of Noxa in proliferation, apoptosis, and autophagy in human adenoid cystic carcinoma","volume":"48","author":"Liang","year":"2019","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.cbi.2022.109978_bib32","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1038\/sj.onc.1203176","article-title":"Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2\/Bcl-XL, c-Jun, and p21CIP1, but independent of p53","volume":"18","author":"Vrana","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2022.109978_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2017.08.019","article-title":"Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3\/miR-183\/\u03b2-TrCP\/SP1 axis-mediated BAX upregulation","volume":"334","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2022.109978_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2018.06.019","article-title":"ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells","volume":"432","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2022.109978_bib35","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2011.06.033","article-title":"Cross talk between mitochondria and NADPH oxidases","volume":"51","author":"Dikalov","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2022.109978_bib36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41467-017-01106-1","article-title":"NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance","volume":"8","author":"Shanmugasundaram","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.109978_bib37","first-page":"2306","article-title":"NOX4\/ROS mediate ethanol-induced apoptosis via MAPK signal pathway in L-02 cells","volume":"41","author":"Yang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cbi.2022.109978_bib38","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1073\/pnas.1406425111","article-title":"Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak","volume":"111","author":"Lindqvist","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2022.109978_bib39","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.2147\/OTT.S281519","article-title":"BCL-2 inhibitor venetoclax induces autophagy-associated cell death, cell cycle arrest, and apoptosis in human breast cancer cells","volume":"13","author":"Alhoshani","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.cbi.2022.109978_bib40","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1038\/sigtrans.2017.12","article-title":"Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells","volume":"2","author":"Luedtke","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2022.109978_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41418-019-0391-9","article-title":"BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics","volume":"27","author":"Villalobos-Ortiz","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2022.109978_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/pharmaceutics8010005","article-title":"Venetoclax (ABT-199) might act as a perpetrator in pharmacokinetic drug-drug interactions","volume":"8","author":"Weiss","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2022.109978_bib43","doi-asserted-by":"crossref","first-page":"26046","DOI":"10.18632\/oncotarget.25433","article-title":"BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose","volume":"9","author":"Lucantoni","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2022.109978_bib44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4161\/auto.27955","article-title":"NOX4 regulates autophagy during energy deprivation","volume":"10","author":"Sciarretta","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2022.109978_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-319-55330-6_16","article-title":"Functional role of Nox4 in autophagy","volume":"982","author":"Forte","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cbi.2022.109978_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","article-title":"p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents","volume":"344","author":"Sui","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2022.109978_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114857","article-title":"Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells","volume":"387","author":"Chiou","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2022.109978_bib48","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/s41467-021-22574-6","article-title":"Selectivity of mRNA degradation by autophagy in yeast","volume":"12","author":"Makino","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.109978_bib49","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1535-7163.MCT-15-0730","article-title":"Expression profile of BCL-2, BCL-XL, and MCL-1 predicts pharmacological response to the BCL-2 selective antagonist venetoclax in multiple myeloma models","volume":"15","author":"Punnoose","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.cbi.2022.109978_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/cdd.2016.105","article-title":"Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling","volume":"24","author":"Peperzak","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2022.109978_bib51","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/s41467-018-05815-z","article-title":"Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity","volume":"9","author":"Soderquist","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.109978_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41419-020-2446-8","article-title":"NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and \"osmotic reprogramming\" in colorectal cancer","volume":"11","author":"Knoll","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.109978_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.525","article-title":"MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.109978_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12885-017-3383-5","article-title":"Potential mechanisms of resistance to venetoclax and strategies to circumvent it","volume":"17","author":"Tahir","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2022.109978_bib55","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41418-020-00692-w","article-title":"Regulation of Bcl-XL by non-canonical NF-\u03baB in the context of CD40-induced drug resistance in CLL","volume":"28","author":"Haselager","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2022.109978_bib56","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/bjc.2017.281","article-title":"Targeting apoptosis in acute myeloid leukaemia","volume":"117","author":"Cassier","year":"2017","journal-title":"Br. J. Cancer"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:10:48Z","timestamp":1757859048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":56,"alternative-id":["S0009279722001831"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109978","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109978"}}